13 Jefferies Group Evolent Health Trades
Jefferies Group acquired 292k Evolent Health shares worth $1.23M. That's 0.01% of their equity portfolio (578th largest holding). The first Evolent Health trade was made in Q4 2022. Since then Jefferies Group bought shares six more times and sold shares on six occasions. The investor's estimated purchase price is $4.2M, resulting in a loss of 71%.
Avg closing price
Price range
Increased shares by 1371.2% (+272k shares)
Q4 2025
Avg closing price
$5.54
Price range
$3.53
-
$8.25
Sold 95.9% shares (-460k shares)
Q3 2025
Avg closing price
$9.73
Price range
$8.38
-
$11.79
Increased shares by 45.1% (+149k shares)
Q2 2025
Avg closing price
$9.14
Price range
$7.21
-
$11.26
Increased shares by 29.7% (+75.8k shares)
Q1 2025
Avg closing price
$10.14
Price range
$8.55
-
$12.60
Increased shares by 276.0% (+187k shares)
Q4 2024
Avg closing price
$17.33
Price range
$10.87
-
$27.13
Sold 61.6% shares (-109k shares)
Q3 2024
Avg closing price
$25.78
Price range
$18.41
-
$32.97
Increased shares by 16313.8% (+176k shares)
Q2 2024
Avg closing price
$25.54
Price range
$19.12
-
$31.93
Sold 89.0% shares (-8.67k shares)
Q1 2024
Avg closing price
$31.91
Price range
$29.41
-
$34.72
Sold 69.7% shares (-22.5k shares)
Q4 2023
Avg closing price
$28.30
Price range
$23.63
-
$33.52
Sold 46.6% shares (-28.1k shares)
Q3 2023
Avg closing price
$27.80
Price range
$25.00
-
$31.40
Increased shares by 66.2% (+24k shares)
Q2 2023
Avg closing price
$32.33
Price range
$28.05
-
$36.44
Sold 11.2% shares (-4.59k shares)
Q1 2023
Avg closing price
$31.62
Price range
$26.35
-
$35.80
New holding (+40.9k shares)
Q4 2022
Avg closing price
$28.67
Price range
$21.96
-
$37.41
